Well Clinic
All-round medical service centre
查詢或預約Enquiry or Appointment
查詢或預約Enquiry or Appointment
查詢或預約Enquiry or Appointment
Hong Kong Well Clinic understands the importance of vaccination and is committed to providing safe and effective vaccine services. We offer a wide range of vaccines, including influenza vaccine, pneumococcal vaccine, herpes zoster vaccine, HPV 9-valent vaccine, etc.
What vaccinations are available at Hong Kong Well Clinic?
Original price for 1 dose:$450
Special Price for 1 dose:$390
Original price for 2 doses:$900
Special price for Price 2 doses:$700 (Indicated for children aged below 9 and never had flu vaccine)
Vaccine Information
The FluMist Quadrivalent Influenza Intranasal Vaccine is a live attenuated vaccine that is administered directly through the nose without injection. After vaccination, it can stimulate the body’s punctual membrane response and cellular immune response to fight against influenza.
Target Group
For people aged 2 to 49 years, but not for certain special groups, such as children taking medication containing aspirin, asthmatics, immunocompromised persons, pregnant women, etc.
Original price for 1 dose:$320
Special Price for 1 dose:$280
Original price for 2 doses:$560
Special Price 2 for doses:$500 (Indicated for children aged below 9 and never had flu vaccine)
Vaccine Information
Fluarix Tetra is an inactivated influenza vaccine (IIV) made from inactivated (killed) virus and is suitable for most people, including pregnant women and the elderly.
Target Group
Individuals aged 6 months and above.
Original price for 1 dose:$1900
Special Price for 1 dose:$1600
Vaccine Information
The Prevnar 20 is indicated for adults aged 18 years and above for the prevention of invasive disease and pneumonia caused by pneumococcal bacteria. In addition to the original 13 serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F), seven new serotypes have been added (8. 10A, 11A, 12F), which are associated with invasive pneumococcal disease (IPD), high lethality, and antibiotic resistance, 10A, 11A, 12F, 15B, 22F, 33F), making it the FDA-approved conjugate pneumococcal vaccine with the most serotypes covered.
Original price for 1 dose:$1600
Special Price for 1 dose:$1500
Vaccine Information
The Prevenar 13 provides long-lasting protection against invasive pneumococcal disease and non-invasive pneumonia caused by pneumococcal bacteria by including 13 of the most common causative organisms and by activating the long-term memory capacity of T-cell lymphocytes.
Original price for 1 dose:$1700
Special Price for 1 dose:$1500
Vaccine Information
It can prevent diseases caused by 15 serotypes of pneumococci: 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F.
Target Group
suitable for infant and adults aged 6 weeks or above
Original price for 1 dose:$1600
Special Price for 1 dose:$1500
Original price for 2 doses:$3200
Special Price for 2 doses:$2800
Original price for 3 doses:$4600
Special Price for 3 doses:$4100
Vaccine Information
The HPV 9-valent Vaccine covers 9 viruses including HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58. These 9 viruses cause cancers and lesions such as cervical, vulvar, vaginal and anal cancers.
The diseases caused by HPV are not limited to women. Men and women who have sexual experience can be infected. In addition, if a woman is infected with HPV, she may infect her newborn during childbirth.
Target Group
Injections should be given at 0-2-6 months, i.e. 3 doses within 6 months, with 2 months and 4 months in between.
Original price for 2 doses:$5780
Special Price for 2 doses:$4980
Vaccine Information
Herpes zoster, is a painful condition caused by the varicella zoster virus. Herpes zoster can affect people of all ages and is especially common in the elderly. Sometimes even the slightest touch of the skin can cause severe pain, which can seriously affect the daily life of the patient.
Recommended by the Centers for Disease Control and Prevention (CDC) as the herpes zoster vaccine of choice, the second generation Shingrix shingles vaccine is more effective than the first generation Zostavax shingles vaccine in preventing herpes zoster and the neurological pain associated with it, as well as reducing the risk of other complications. If you have received the first generation Zostavax Shingles vaccine, it is recommended to receive the second generation Shingrix Shingles vaccine.
**Two doses of this vaccine are required to provide long term protection, 2-6 months apart**.
Target Group
For high-risk individuals aged 18 years or above and individuals aged 50 years or above.
Original price for 1 dose:$1200
Special Price for 1 dose:$900
Vaccine Information
Measles, chickenpox, German measles and mumps are some of the childhood diseases that are mainly spread by droplet or airborne transmission. Measles can lead to complications such as otitis media and bronchitis. Chickenpox is a disease caused by the varicella-zoster virus and can be spread by direct contact with a person who has the virus. In severe cases, chickenpox may lead to complications such as pneumonia, encephalitis and may even be life-threatening. German measles may cause arthritis, encephalitis, conjunctivitis, and in pregnant women, miscarriage or teratology. Mumps may cause hearing loss and inflammation of the ovaries or testicles.
The MMRV vaccine is effective against measles, mumps, rubella and chickenpox and is suitable for infants from 1 year of age.
Original price for 1 dose:$450
Special Price for 1 dose:$384
Original price for 2 doses:$978
Special Price for 2 doses:$768
Original price for 3 doses:$1450
Special Price for 3 doses:$1250
Vaccine Information
Hepatitis B is a liver disease caused by the Hepatitis B Virus (HBV). Carriers of the virus are at risk of developing life-threatening chronic liver diseases such as cirrhosis and liver cancer. Hepatitis B vaccine contains purified Hepatitis B surface antigen, which has been proven to be safe and effective in preventing Hepatitis B virus infection and its complications, and is recommended for high-risk individuals.
Hepatitis B antigen and antibody test (within the last 3 months) is required before vaccination to confirm whether you are a carrier or have existing antibodies and whether you are suitable to receive the vaccination.
If no valid report is produced, additional blood test fee will be charged.
Target Group
suitable for people aged 16 or above.
Vaccination method
Intramuscular injection, a total of 3 doses are required for full effect.
Vaccination schedule
The second dose should be given one month after the first dose, and the third dose should be given six months after the second dose
Original price for 1 dose:$3300
Special Price for 1 dose:$2700
What is RSV?
RSV stands for Human Respiratory Syncytical virus (Respiratory Syncytical Virus, RSV), which can cause severe lower respiratory tract infections in children and older adults. It usually causes mild cold-like symptoms such as coughing, sneezing, runny nose, nasal congestion, chills, low-grade fever and loss of appetite. RSV tends to attack more the lower respiratory tract (bronchioles) than common cold, and thus produces sputum that blocks the tiny airways, which can cause “acute bronchiolitis”
It is difficult for the human immune system to develop immunity to it, so the course of the disease after infection will be longer than that of a common cold, which can last up to 2 weeks
Is rapid test for RSV available?
Yes, and using a cotton swab to obtain nasopharyngeal secretions. It is similar to the rapid test for influenza and COVID-19.
After obtaining the specimen, the results can be known in about 5 minutes, which can help doctors confirm the diagnosis and also allow patients and their families to be reassured
What are the treatments for RSV?
Currently, no specific drugs exist to treat RSV infection, so “symptomatic treatment” is mainly used, including hydration and electrolyte replacement, respiratory therapy, bronchodilators, etc.
Is RSV vaccine available?
A new RSV vaccine with a protective efficacy of 82.6% for adults aged 60 and above has been registered in Hong Kong.
In older adults with an underlying medical condition, such as cardiovascular disease and endocrine-metabolic disease, the vaccine is 94.6% effective.
Resources:
https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Arexvy/pdf/AREXVY.PD